Selected research
Industry Research
Quetiapine Industry Research Report 2026
Market perspective
The global Quetiapine market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Quetiapine is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Quetiapine is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Quetiapine is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Quetiapine include XiaoGan ShenYuan ChemPharm, Teva, Sun Pharmaceutical, Sandoz, Qilu Pharmaceutical, Nanjing Sunlida Biological Technology, Mylan, Lupin and Hetero, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Quetiapine market in terms of revenue (US$ million) and, where applicable, sales volume (kg), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/kg) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Quetiapine Market by Company
XiaoGan ShenYuan ChemPharm
Teva
Sun Pharmaceutical
Sandoz
Qilu Pharmaceutical
Nanjing Sunlida Biological Technology
Mylan
Lupin
Hetero
Shanghai Haoyuan Chemexpress
Dr. Reddy's
Aurobindo
AstraZeneca
Wuhan Fortuna Chemical
Waterstone Technology
Toronto Research Chemicals
Nanjing Chemlin Chemical
EMMX Biotechnology
BOC Sciences
AlliChem
Quetiapine Segment by Type
Purity 97%
Purity 98%
Others
Quetiapine Segment by Application
Adult
Aged
Quetiapine Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Quetiapine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Quetiapine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Quetiapine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Quetiapine manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Quetiapine by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Quetiapine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Purity 97%
- Purity 98%
- Others
Applications
- Adult
- Aged
Companies covered
- XiaoGan ShenYuan ChemPharm
- Teva
- Sun Pharmaceutical
- Sandoz
- Qilu Pharmaceutical
- Nanjing Sunlida Biological Technology
- Mylan
- Lupin
- Hetero
- Shanghai Haoyuan Chemexpress
- Dr. Reddy's
- Aurobindo
- AstraZeneca
- Wuhan Fortuna Chemical
- Waterstone Technology
- Toronto Research Chemicals
- Nanjing Chemlin Chemical
- EMMX Biotechnology
- BOC Sciences
- AlliChem
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Quetiapine Market Size (2021-2032)
- 2.2.2 Global Quetiapine Sales (2021-2032)
- 2.2.3 Global Quetiapine Market Average Price (2021-2032)
- 2.3 Quetiapine by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Purity 97%
- 2.3.3 Purity 98%
- 2.3.4 Others
- 2.4 Quetiapine by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Adult
- 2.4.3 Aged
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Quetiapine Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Quetiapine Sales (kg) of Manufacturers (2021-2026)
- 3.3 Global Quetiapine Revenue of Manufacturers (2021-2026)
- 3.4 Global Quetiapine Average Price by Manufacturers (2021-2026)
- 3.5 Global Quetiapine Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Quetiapine, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Quetiapine, Product Type & Application
- 3.8 Global Manufacturers of Quetiapine, Established Date
- 3.9 Global Quetiapine Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 XiaoGan ShenYuan ChemPharm
- 4.1.1 XiaoGan ShenYuan ChemPharm Company Information
- 4.1.2 XiaoGan ShenYuan ChemPharm Business Overview
- 4.1.3 XiaoGan ShenYuan ChemPharm Quetiapine Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 XiaoGan ShenYuan ChemPharm Quetiapine Product Portfolio
- 4.1.5 XiaoGan ShenYuan ChemPharm Recent Developments
- 4.2 Teva
- 4.2.1 Teva Company Information
- 4.2.2 Teva Business Overview
- 4.2.3 Teva Quetiapine Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Teva Quetiapine Product Portfolio
- 4.2.5 Teva Recent Developments
- 4.3 Sun Pharmaceutical
- 4.3.1 Sun Pharmaceutical Company Information
- 4.3.2 Sun Pharmaceutical Business Overview
- 4.3.3 Sun Pharmaceutical Quetiapine Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Sun Pharmaceutical Quetiapine Product Portfolio
- 4.3.5 Sun Pharmaceutical Recent Developments
- 4.4 Sandoz
- 4.4.1 Sandoz Company Information
- 4.4.2 Sandoz Business Overview
- 4.4.3 Sandoz Quetiapine Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Sandoz Quetiapine Product Portfolio
- 4.4.5 Sandoz Recent Developments
- 4.5 Qilu Pharmaceutical
- 4.5.1 Qilu Pharmaceutical Company Information
- 4.5.2 Qilu Pharmaceutical Business Overview
- 4.5.3 Qilu Pharmaceutical Quetiapine Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Qilu Pharmaceutical Quetiapine Product Portfolio
- 4.5.5 Qilu Pharmaceutical Recent Developments
- 4.6 Nanjing Sunlida Biological Technology
- 4.6.1 Nanjing Sunlida Biological Technology Company Information
- 4.6.2 Nanjing Sunlida Biological Technology Business Overview
- 4.6.3 Nanjing Sunlida Biological Technology Quetiapine Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Nanjing Sunlida Biological Technology Quetiapine Product Portfolio
- 4.6.5 Nanjing Sunlida Biological Technology Recent Developments
- 4.7 Mylan
- 4.7.1 Mylan Company Information
- 4.7.2 Mylan Business Overview
- 4.7.3 Mylan Quetiapine Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Mylan Quetiapine Product Portfolio
- 4.7.5 Mylan Recent Developments
- 4.8 Lupin
- 4.8.1 Lupin Company Information
- 4.8.2 Lupin Business Overview
- 4.8.3 Lupin Quetiapine Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Lupin Quetiapine Product Portfolio
- 4.8.5 Lupin Recent Developments
- 4.9 Hetero
- 4.9.1 Hetero Company Information
- 4.9.2 Hetero Business Overview
- 4.9.3 Hetero Quetiapine Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Hetero Quetiapine Product Portfolio
- 4.9.5 Hetero Recent Developments
- 4.10 Shanghai Haoyuan Chemexpress
- 4.10.1 Shanghai Haoyuan Chemexpress Company Information
- 4.10.2 Shanghai Haoyuan Chemexpress Business Overview
- 4.10.3 Shanghai Haoyuan Chemexpress Quetiapine Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Shanghai Haoyuan Chemexpress Quetiapine Product Portfolio
- 4.10.5 Shanghai Haoyuan Chemexpress Recent Developments
- 4.11 Dr. Reddy's
- 4.11.1 Dr. Reddy's Company Information
- 4.11.2 Dr. Reddy's Business Overview
- 4.11.3 Dr. Reddy's Quetiapine Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Dr. Reddy's Quetiapine Product Portfolio
- 4.11.5 Dr. Reddy's Recent Developments
- 4.12 Aurobindo
- 4.12.1 Aurobindo Company Information
- 4.12.2 Aurobindo Business Overview
- 4.12.3 Aurobindo Quetiapine Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Aurobindo Quetiapine Product Portfolio
- 4.12.5 Aurobindo Recent Developments
- 4.13 AstraZeneca
- 4.13.1 AstraZeneca Company Information
- 4.13.2 AstraZeneca Business Overview
- 4.13.3 AstraZeneca Quetiapine Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 AstraZeneca Quetiapine Product Portfolio
- 4.13.5 AstraZeneca Recent Developments
- 4.14 Wuhan Fortuna Chemical
- 4.14.1 Wuhan Fortuna Chemical Company Information
- 4.14.2 Wuhan Fortuna Chemical Business Overview
- 4.14.3 Wuhan Fortuna Chemical Quetiapine Sales, Revenue and Gross Margin (2021-2026)
- 4.14.4 Wuhan Fortuna Chemical Quetiapine Product Portfolio
- 4.14.5 Wuhan Fortuna Chemical Recent Developments
- 4.15 Waterstone Technology
- 4.15.1 Waterstone Technology Company Information
- 4.15.2 Waterstone Technology Business Overview
- 4.15.3 Waterstone Technology Quetiapine Sales, Revenue and Gross Margin (2021-2026)
- 4.15.4 Waterstone Technology Quetiapine Product Portfolio
- 4.15.5 Waterstone Technology Recent Developments
- 4.16 Toronto Research Chemicals
- 4.16.1 Toronto Research Chemicals Company Information
- 4.16.2 Toronto Research Chemicals Business Overview
- 4.16.3 Toronto Research Chemicals Quetiapine Sales, Revenue and Gross Margin (2021-2026)
- 4.16.4 Toronto Research Chemicals Quetiapine Product Portfolio
- 4.16.5 Toronto Research Chemicals Recent Developments
- 4.17 Nanjing Chemlin Chemical
- 4.17.1 Nanjing Chemlin Chemical Company Information
- 4.17.2 Nanjing Chemlin Chemical Business Overview
- 4.17.3 Nanjing Chemlin Chemical Quetiapine Sales, Revenue and Gross Margin (2021-2026)
- 4.17.4 Nanjing Chemlin Chemical Quetiapine Product Portfolio
- 4.17.5 Nanjing Chemlin Chemical Recent Developments
- 4.18 EMMX Biotechnology
- 4.18.1 EMMX Biotechnology Company Information
- 4.18.2 EMMX Biotechnology Business Overview
- 4.18.3 EMMX Biotechnology Quetiapine Sales, Revenue and Gross Margin (2021-2026)
- 4.18.4 EMMX Biotechnology Quetiapine Product Portfolio
- 4.18.5 EMMX Biotechnology Recent Developments
- 4.19 BOC Sciences
- 4.19.1 BOC Sciences Company Information
- 4.19.2 BOC Sciences Business Overview
- 4.19.3 BOC Sciences Quetiapine Sales, Revenue and Gross Margin (2021-2026)
- 4.19.4 BOC Sciences Quetiapine Product Portfolio
- 4.19.5 BOC Sciences Recent Developments
- 4.20 AlliChem
- 4.20.1 AlliChem Company Information
- 4.20.2 AlliChem Business Overview
- 4.20.3 AlliChem Quetiapine Sales, Revenue and Gross Margin (2021-2026)
- 4.20.4 AlliChem Quetiapine Product Portfolio
- 4.20.5 AlliChem Recent Developments
5 Global Quetiapine Market Scenario by Region
- 5.1 Global Quetiapine Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Quetiapine Sales by Region: 2021-2032
- 5.2.1 Global Quetiapine Sales by Region: 2021-2026
- 5.2.2 Global Quetiapine Sales by Region: 2027-2032
- 5.3 Global Quetiapine Revenue by Region: 2021-2032
- 5.3.1 Global Quetiapine Revenue by Region: 2021-2026
- 5.3.2 Global Quetiapine Revenue by Region: 2027-2032
- 5.4 North America Quetiapine Market Facts & Figures by Country
- 5.4.1 North America Quetiapine Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Quetiapine Sales by Country (2021-2032)
- 5.4.3 North America Quetiapine Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Quetiapine Market Facts & Figures by Country
- 5.5.1 Europe Quetiapine Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Quetiapine Sales by Country (2021-2032)
- 5.5.3 Europe Quetiapine Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Quetiapine Market Facts & Figures by Country
- 5.6.1 Asia Pacific Quetiapine Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Quetiapine Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Quetiapine Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Quetiapine Market Facts & Figures by Country
- 5.7.1 South America Quetiapine Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Quetiapine Sales by Country (2021-2032)
- 5.7.3 South America Quetiapine Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Quetiapine Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Quetiapine Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Quetiapine Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Quetiapine Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Quetiapine Sales by Type (2021-2032)
- 6.1.1 Global Quetiapine Sales by Type (2021-2032) & (kg)
- 6.1.2 Global Quetiapine Sales Market Share by Type (2021-2032)
- 6.2 Global Quetiapine Revenue by Type (2021-2032)
- 6.2.1 Global Quetiapine Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Quetiapine Revenue Market Share by Type (2021-2032)
- 6.3 Global Quetiapine Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Quetiapine Sales by Application (2021-2032)
- 7.1.1 Global Quetiapine Sales by Application (2021-2032) & (kg)
- 7.1.2 Global Quetiapine Sales Market Share by Application (2021-2032)
- 7.2 Global Quetiapine Revenue by Application (2021-2032)
- 7.2.1 Global Quetiapine Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Quetiapine Revenue Market Share by Application (2021-2032)
- 7.3 Global Quetiapine Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Quetiapine Value Chain Analysis
- 8.1.1 Quetiapine Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Quetiapine Production Mode & Process
- 8.2 Quetiapine Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Quetiapine Distributors
- 8.2.3 Quetiapine Customers
9 Global Quetiapine Analyzing Market Dynamics
- 9.1 Quetiapine Industry Trends
- 9.2 Quetiapine Industry Drivers
- 9.3 Quetiapine Industry Opportunities and Challenges
- 9.4 Quetiapine Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst